A. Taieb

发表

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

F. Brun-Vézinet, G. Peytavin, G. Chêne, 2006, AIDS.

Improved Sensitivity of Human Immunodeficiency Virus Type 2 Subtype B Plasma Viral Load Assay

F. Brun-Vézinet, D. Descamps, G. Chêne, 2005, Journal of Clinical Microbiology.

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.

F. Brun-Vézinet, A. Calmy, A. van Sighem, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort

F. Brun-Vézinet, D. Descamps, G. Chêne, 2006, AIDS.

Selection of K65R Mutation in HIV-2-Infected Patients Receiving Tenofovir-Containing Regimen

F. Brun-Vézinet, G. Peytavin, D. Descamps, 2004, Antiviral therapy.

Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.

C. Charpentier, F. Brun-Vézinet, J. Capeau, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vitro Phenotypic Susceptibility to Nucleoside Reverse Transcriptase Inhibitors of HIV-2 Isolates with the Q151M Mutation in the Reverse Transcriptase Gene

F. Brun-Vézinet, G. Peytavin, D. Descamps, 2005, Antiviral therapy.

Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8).

F. Raffi, M. Carrieri, C. Protopopescu, 2007, The International journal on drug policy.

Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort

F. Brun-Vézinet, B. Autran, R. Thiébaut, 2011, AIDS.

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

F. Brun-Vézinet, B. Autran, G. Peytavin, 2009, AIDS.

An International Collaboration To Standardize HIV-2 Viral Load Assays: Results from the 2009 ACHIEV2E Quality Control Study

G. Gottlieb, M. Wainberg, F. Brun-Vézinet, 2011, Journal of Clinical Microbiology.

Is long‐term virological response related to CCR5 Δ32 deletion in HIV‐1‐infected patients started on highly active antiretroviral therapy?

C. Katlama, F. Raffi, C. Leport, 2010, HIV medicine.